$34 mil over the next 15 yrs in royalties, page-13

Too true kipp.

The funny thing for me is that with a forecast EBIT (not revenue) of AUD 2.3 MM a year for the next 15 years (if Mr Xi's forecast sales are accurate) and the current mkt cap 24MM then a (forecast) PE of about 10 results. I've always thought a PE of 10 was a good buy and critically that PE doesn't account for any income from WestCoast, or potential income from artimist or any of the other Oromist products.

For the first time ever we have been given data which supports price discovery on this stock and it sure appears undervalued to me.

Interestingly, as Eddy points out, a Trump win has been very good for NASDAQ Biotech's.

All in all this has been a good beginning to asset monetisation and for the first time I'm starting to think like ablm that a CR isn't on the cards in the near term.